New developments in anti-tumor efficacy and malignant transformation of human natural killer cells.


For decades, the driving force behind many immunologic studies has been the hope of augmenting anti-cancer therapy through targeted immune-based strategies. The question remains: can immune cells be successfully manipulated to augment chemotherapy and aid in the elimination of malignancy? Such efforts have included work with natural killer (NK) cells, large… (More)


  • Presentations referencing similar topics